| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/22/2002 | US20020115102 Novel protein |
| 08/22/2002 | US20020115101 Including large number of spots of sample solution arranged on base plate by supplying solution from dispenser onto plate, wherein solution is supplied a plurality of times to form one spot and solution is dried, thickened, solidified |
| 08/22/2002 | US20020115098 Detection of genetic agjustment in nucleotide sequences; obtain solid support, incubate with nucleotide sequence and probes, monitor signal from solid support |
| 08/22/2002 | US20020115093 Combined polynucleotide sequences as discrete assay endpoints |
| 08/22/2002 | US20020115091 Compounds for use as tools in sequence analysis |
| 08/22/2002 | US20020115090 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 08/22/2002 | US20020115089 Simultaneous collection of DNA and non-nucleic analytes |
| 08/22/2002 | US20020115088 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 08/22/2002 | US20020115086 Diagnosing allergic dermatitis in humans; obtain cells, extract nucleotide sequence, incubate with probes, measure concentration of preferential interleukin, ampified concentrations of interleukins in skin indicates allergic |
| 08/22/2002 | US20020115084 Detection of mycosphaerella using the polymerase chain reaction |
| 08/22/2002 | US20020115083 Detecting preferential nucleotide sequences in sample; obtain messenger ribonucleic acid sequences, translate, recover polypeptide, incubate with target molecule, evaluate activity of protein |
| 08/22/2002 | US20020115081 Nucleotide sequences coding polypeptide for use in the the treatament of cardiovasculAR disorders |
| 08/22/2002 | US20020115080 Detection of mutations in genes by specific LNA primers |
| 08/22/2002 | US20020115076 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |
| 08/22/2002 | US20020115072 Probe bound substrate, process for manufacturing same, probe array, method of detecting target substance, method of specifying nucleotide sequence of single-stranded nucleic acid in sample, and quantitative determination of target substance in sample |
| 08/22/2002 | US20020115070 Methods and apparatus for analyzing gene expression data |
| 08/22/2002 | US20020115068 Matrix screening method |
| 08/22/2002 | US20020115067 Asymmetric benzoxanthene dye labelling reagents |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020114828 For facilitating the transfer of nucleic acids into cells; gene therapy; transfection |
| 08/22/2002 | US20020114818 DNA sequence coated onto carrier particle, DNA sequence comprising promoter operative in cells of a mammal and a protein coding region coding for determinant of hantavirus protein |
| 08/22/2002 | US20020114811 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex |
| 08/22/2002 | US20020114810 Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114797 Composition and methods for modulating the length of telomeres |
| 08/22/2002 | US20020114792 Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
| 08/22/2002 | US20020114790 Ablating lymphoid cells, infusing stem cells infected with transducing virus coding containing nucleic acid encoding polypeptide; gene expression; retrovirus |
| 08/22/2002 | US20020114787 Tolerance to natural antibody antigens |
| 08/22/2002 | US20020114784 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| 08/22/2002 | US20020114783 Human gene therapy for inherited or acquired proliferative ocular disease; transduction of mitotically active and inactive cells |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | US20020114734 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization |
| 08/22/2002 | US20020112758 Pressure vessel systems and methods for dispensing liquid chemical compositions |
| 08/22/2002 | DE10108212A1 Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände Fusion protein for secretion of value protein in bacterial supernatants |
| 08/22/2002 | DE10108211A1 Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen Use of fusion proteins whose N-terminal portion consists of a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 08/22/2002 | DE10106370A1 Oligonukleotidsonden zur Detektion von parodontopathogenen Bakterien mittels in situ-Hybridisierung Oligonucleotide probes for the detection of periodontal bacteria by means of in situ hybridization |
| 08/22/2002 | DE10106339A1 Verfahren zum Hochdurchsatz-Screening von Kandidaten-Verbindungen über die Hochdurchsatz-Direktsynthese von rekombinanten Polypeptiden A method for high-throughput screening of candidate compounds on the high-throughput direct synthesis of recombinant polypeptides |
| 08/22/2002 | DE10106199A1 Verfahren zur Isolierung von Nukleinsäuren aus einer nukleinsäurehaltigen flüssigen Probe A method for isolating nucleic acids from a nucleic acid containing liquid sample |
| 08/22/2002 | DE10104584A1 Medane-Gene und- Proteine Medane genes and- proteins |
| 08/22/2002 | DE10100238A1 Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests A method for predicting the risk potential for cancer diseases and inflammatory bowel disease and related tests |
| 08/22/2002 | CA2856986A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2854685A1 Optimized messenger rna |
| 08/22/2002 | CA2776701A1 T1r taste receptors and genes encoding same |
| 08/22/2002 | CA2443266A1 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes |
| 08/22/2002 | CA2440892A1 Method of transferring selected molecules |
| 08/22/2002 | CA2440743A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | CA2439129A1 Novel cellular adhesion molecule of activated leukocyte |
| 08/22/2002 | CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438356A1 Improved method for production of secreted proteins in fungi |
| 08/22/2002 | CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | CA2438121A1 Oligonucleotide probes used to detect parodontopathogenic bacteria by in situ hybridization |
| 08/22/2002 | CA2437887A1 Methods of using mammalian rnase h and compositions thereof |
| 08/22/2002 | CA2437873A1 Neurotonin and use thereof |
| 08/22/2002 | CA2437868A1 Expression of human milk proteins in transgenic plants |
| 08/22/2002 | CA2437819A1 Feed additive compositions and methods |
| 08/22/2002 | CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | CA2437807A1 Pin1 as marker for abnormal cell growth |
| 08/22/2002 | CA2437799A1 Fusion proteins based upon somatostatin receptors |
| 08/22/2002 | CA2437784A1 Pin1 as a marker for prostate cancer |
| 08/22/2002 | CA2437737A1 Methods and compositions of amplifying rna |
| 08/22/2002 | CA2437583A1 Dna markers for meat tenderness |
| 08/22/2002 | CA2437576A1 Method for evaluating therapeutic efficacy |
| 08/22/2002 | CA2437246A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/22/2002 | CA2436889A1 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 08/22/2002 | CA2436713A1 Proteins and nucleic acids encoding same |
| 08/22/2002 | CA2436203A1 Identification of seeds or plants using phenotyic markers |
| 08/22/2002 | CA2434264A1 An optical method for testing sensitivity of cells |
| 08/22/2002 | CA2433936A1 Localized myocardial injection method for treating ischemic myocardium |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2433079A1 Regulatory genes suitable for use in gene expression |
| 08/22/2002 | CA2433057A1 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| 08/22/2002 | CA2432364A1 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | CA2432111A1 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | CA2430726A1 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | CA2425732A1 Optimized messenger rna |
| 08/22/2002 | CA2335412A1 Cloning vector comprising a system for direct selection of recombinants |
| 08/21/2002 | EP1233074A1 Vegf responsive cell-based assay for determining vegf bioactivity |
| 08/21/2002 | EP1233070A2 Method for producing L-glutamic acid |
| 08/21/2002 | EP1233068A2 Method for producing L-glutamic acid |
| 08/21/2002 | EP1233066A2 Peptide vector |
| 08/21/2002 | EP1233065A1 G-CSF analog compositions and methods |
| 08/21/2002 | EP1233064A1 Modified factor VIII cDNA and its use for the production of factor VIII |
| 08/21/2002 | EP1233063A2 Transgenic animals containing a dominant negative mutant form of the p85 subunit of pi-3 kinase |
| 08/21/2002 | EP1233062A2 Destabilisation of viral quasi-species distributions - avoiding resistance phenomena |
| 08/21/2002 | EP1233061A2 A method for cloning of a gene for pol I type DNA polymerase |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1233026A1 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 08/21/2002 | EP1233025A1 Receptor expression cells and use thereof |
| 08/21/2002 | EP1233024A2 25466, a human transporter family member and uses therefor |
| 08/21/2002 | EP1233023A1 Transcription factor and dna thereof |
| 08/21/2002 | EP1232759A1 Gene transfer-mediated angiogenesis therapy |
| 08/21/2002 | EP1232758A1 Polynucleotide formulated for improved intracellular transfer |
| 08/21/2002 | EP1232502A1 Magnetic glass particles, method for their preparation and uses thereof |
| 08/21/2002 | EP1232396A2 Assay of isomerised and/or optically inverted proteins |
| 08/21/2002 | EP1232287A2 Oligomer array with pna and/or dna oligomers on a surface |